Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4520 | 1697 | 43.0 | 75% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CHOLERA TOXIN | Author keyword | 31 | 17% | 10% | 164 |
2 | HEAT LABILE ENTEROTOXIN | Author keyword | 29 | 52% | 2% | 39 |
3 | RECOMBINANT CHOLERA TOXIN B SUBUNIT RCTB | Author keyword | 23 | 100% | 1% | 10 |
4 | IMMUNOBIOL VACCINE | Address | 22 | 37% | 3% | 47 |
5 | MUCOSAL ADJUVANT | Author keyword | 14 | 36% | 2% | 32 |
6 | MUCOSAL ADJUVANTS | Author keyword | 12 | 56% | 1% | 15 |
7 | E COLI HEAT LABILE ENTEROTOXIN | Author keyword | 12 | 86% | 0% | 6 |
8 | ETXB | Author keyword | 12 | 86% | 0% | 6 |
9 | INTRANASAL IMMUNIZATION | Author keyword | 8 | 25% | 2% | 29 |
10 | ESCHERICHIA COLI HEAT LABILE ENTEROTOXIN | Author keyword | 7 | 56% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ADP RIBOSYLTRANSFERASE ACTIVITY | 118 | 54% | 9% | 153 |
2 | HEAT LABILE ENTEROTOXIN | 110 | 30% | 18% | 309 |
3 | CHOLERA TOXIN | 64 | 13% | 27% | 465 |
4 | TOXIN B SUBUNIT | 52 | 23% | 12% | 196 |
5 | MUCOSAL ADJUVANTICITY | 42 | 76% | 2% | 29 |
6 | TRACE AMOUNT | 42 | 73% | 2% | 32 |
7 | INTRANASAL IMMUNIZATION | 33 | 19% | 9% | 160 |
8 | B SUBUNIT | 30 | 16% | 10% | 171 |
9 | NONTOXIC MUTANT | 24 | 57% | 2% | 29 |
10 | LT IIB | 24 | 82% | 1% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Mucosal vaccines: the promise and the challenge | 2006 | 451 | 109 | 23% |
Recent progress in mucosal vaccine development: potential and limitations | 2012 | 98 | 141 | 28% |
Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic | 1999 | 153 | 59 | 88% |
Mucosal immunity and vaccines | 2005 | 504 | 86 | 22% |
A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants | 2002 | 136 | 48 | 54% |
Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit | 2010 | 50 | 76 | 37% |
Cholera toxin structure, gene regulation and pathophysiological and immunological aspects | 2008 | 69 | 86 | 42% |
Cholera toxin - A foe & a friend | 2011 | 41 | 46 | 39% |
Nalt- versus Peyer's-patch-mediated mucosal immunity | 2004 | 283 | 93 | 25% |
Buccal and sublingual vaccine delivery | 2014 | 4 | 79 | 37% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMMUNOBIOL VACCINE | 22 | 37% | 2.8% | 47 |
2 | MICROBIAL DIS BACTERIOL SEROL | 6 | 100% | 0.2% | 4 |
3 | PROD 1 | 5 | 60% | 0.4% | 6 |
4 | WITEBSKY MICROBIAL PATHOGENESIS IMMUNOL | 4 | 14% | 1.5% | 26 |
5 | PREVENT VIRAL DIS | 3 | 45% | 0.3% | 5 |
6 | HUMAN VACCINE PROD | 2 | 38% | 0.3% | 5 |
7 | GI CELL BIOL | 2 | 19% | 0.6% | 10 |
8 | U721 | 2 | 40% | 0.2% | 4 |
9 | GUVAX | 1 | 21% | 0.4% | 6 |
10 | AUSTRALIAN COUNCIL ARC EXCELLENCE STRUCT | 1 | 50% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000151398 | VET ANAT PATHOL B14//ACINAR CELL CULTURE//COMPREHENS CANC UNIV STN |
2 | 0.0000130930 | ETEC//ENTEROTOXIGENIC ESCHERICHIA COLI//CFA I |
3 | 0.0000116061 | VACCINE DELIVERY//PLG MICROPARTICLES//ADJUVANT UNIT |
4 | 0.0000089768 | M CELL//M CELLS//FOLLICLE ASSOCIATED EPITHELIUM |
5 | 0.0000089374 | ORAL TOLERANCE//EPICUTANEOUS IMMUNIZATION//MUCOSAL TOLERANCE |
6 | 0.0000082279 | STN GENE//SALMONELLA ENTEROTOXIN//SUS SALVANIUS |
7 | 0.0000073443 | LIVE ATTENUATED INFLUENZA VACCINE//LAIV//OCULO RESPIRATORY SYNDROME |
8 | 0.0000069315 | ISCOMS//ISCOM//QUIL A |
9 | 0.0000065540 | CCR9//CCL28//ANTIGEN P ENTAT GRP |
10 | 0.0000065011 | DUAL COLOR ENZYME LINKED IMMUNOSPOT ELISPOT ASSAY//ILISPOT//IMMUNOFLUORESCENCE DIGITAL IMAGE PROCESSING SYSTEM |